Preventing blood transfusion failures: FMEA, an effective assessment method

• Hoofdauteurs: Zhila Najafpour (Auteur), Mojtaba Hasoumi (Auteur), Faranak Behzadi (Auteur), Efat Mohamadi (Auteur), Mohamadreza Jafary (Auteur), Morteza Saeedi (Auteur)
• Formaat: Boek
• Gepubliceerd in: BMC, 2017-06-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.
• Notes: 10.1186/s12913-017-2380-3; 1472-6963
• Keywords: Blood transfusion; Failure modes; Risk analysis; FMEA; Public aspects of medicine; RA1-1270
• Source: BMC Health Services Research, Vol 17, Iss 1, Pp 1-9 (2017)

Abstract Background Failure Mode and Effect Analysis (FMEA) is a method used to assess the risk of failures and harms to patients during the medical process and to identify the associated clinical issues. The aim of this study was to conduct an assessment of blood transfusion process in a teaching general hospital, using FMEA as the method. Methods A structured FMEA was recruited in our study performed in 2014, and corrective actions were implemented and re-evaluated after 6 months. Sixteen 2-h sessions were held to perform FMEA in the blood transfusion process, including five steps: establishing the context, selecting team members, analysis of the processes, hazard analysis, and developing a risk reduction protocol for blood transfusion. Results Failure modes with the highest risk priority numbers (RPNs) were identified. The overall RPN scores ranged from 5 to 100 among which, four failure modes were associated with RPNs over 75. The data analysis indicated that failures with the highest RPNs were: labelling (RPN: 100), transfusion of blood or the component (RPN: 100), patient identification (RPN: 80) and sampling (RPN: 75). Conclusion The results demonstrated that mis-transfusion of blood or blood component is the most important error, which can lead to serious morbidity or mortality. Provision of training to the personnel on blood transfusion, knowledge raising on hazards and appropriate preventative measures, as well as developing standard safety guidelines are essential, and must be implemented during all steps of blood and blood component transfusion.